(Q40329672)

English

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness

scientific article published on 13 April 2011

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

19 September 2017

A human challenge model for dengue infection reveals a possible protective role for sustained interferon gamma levels during the acute phase of illness (English)

1 reference

Europe PubMed Central

19 September 2017

0 references

author name string

V J Gunther

1

1 reference

Europe PubMed Central

19 September 2017

R Putnak

2

1 reference

Europe PubMed Central

19 September 2017

K H Eckels

3

1 reference

Europe PubMed Central

19 September 2017

M P Mammen

4

1 reference

Europe PubMed Central

19 September 2017

J M Scherer

5

1 reference

Europe PubMed Central

19 September 2017

A Lyons

6

1 reference

Europe PubMed Central

19 September 2017

M B Sztein

7

1 reference

Europe PubMed Central

19 September 2017

W Sun

8

1 reference

Europe PubMed Central

19 September 2017

language of work or name

0 references

publication date

13 April 2011

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

29

1 reference

Europe PubMed Central

19 September 2017

3895-3904

1 reference

Europe PubMed Central

19 September 2017

22

1 reference

Europe PubMed Central

19 September 2017

Sequential production of cytokines by dengue virus-infected human peripheral blood leukocyte cultures

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

HLA-A and -B allele associations with secondary dengue virus infections correlate with disease severity and the infecting viral serotype in ethnic Thais.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Human dendritic cells are activated by dengue virus infection: enhancement by gamma interferon and implications for disease pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Activation of T lymphocytes in dengue virus infections. High levels of soluble interleukin 2 receptor, soluble CD4, soluble CD8, interleukin 2, and interferon-gamma in sera of children with dengue

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Infection of human cells by dengue virus is modulated by different cell types and viral strains

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Propagation of dengue virus strains in unweaned mice.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Experimental infection of New World monkeys with dengue and yellow fever viruses.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Quantity of dengue virus required to infect rhesus monkeys

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Studies on the pathogenesis of dengue infection in monkeys. II. Clinical laboratory responses to heterologous infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Studies on the pathogenesis of dengue infection in monkeys. I. Clinical laboratory responses to primary infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Modification of dengue virus strains by passage in primary dog kidney cells: preparation of candidate vaccines and immunization of monkeys.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

A live attenuated dengue-1 vaccine candidate (45AZ5) passaged in primary dog kidney cell culture is attenuated and immunogenic for humans

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Protection of Rhesus monkeys against dengue virus challenge after tetravalent live attenuated dengue virus vaccination.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Sonographic findings of healthy volunteers infected with dengue virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Dengue-specific T cell responses in peripheral blood mononuclear cells obtained prior to secondary dengue virus infections in Thai schoolchildren

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Further Experiments in the Etiology of Dengue Fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Experimental studies on dengue. I. Isolation, identification and modification of the virus

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

PRODUCTION OF IMMUNITY TO DENGUE WITH VIRUS MODIFIED BY PROPAGATION IN MICE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Early Immune Activation in Acute Dengue Illness Is Related to Development of Plasma Leakage and Disease Severity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Characterisation of lymphocyte response and cytokine patterns in patients with dengue fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Systemic host inflammatory and coagulation response in the Dengue virus primo-infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Pathophysiologic and prognostic role of cytokines in dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Detection of circulant tumor necrosis factor-alpha, soluble tumor necrosis factor p75 and interferon-gamma in Brazilian patients with dengue fever and dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Activation via TCR or IL-2 receptor of a CD8+ suppressor T cell clone: effect on IL-10 production and on proliferation of the suppressor T cell

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Reciprocal control of T helper cell and dendritic cell differentiation

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

The multifaceted relationship between IL-10 and adaptive immunity: putting together the pieces of a puzzle

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Interleukin-10 induces E-selectin on small and large blood vessel endothelial cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Interleukin-10 increases Th1 cytokine production and cytotoxic potential in human papillomavirus-specific CD8(+) cytotoxic T lymphocytes

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

CD8+ T lymphocytes provide helper activity for IgE synthesis in human immunodeficiency virus-infected patients with hyper-IgE.

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Interleukin 12 and tumor necrosis factor alpha are costimulators of interferon gamma production by natural killer cells in severe combined immunodeficiency mice with listeriosis, and interleukin 10 is a physiologic antagonist

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Expression of cytokine mRNAs in murine hearts with acute myocarditis caused by coxsackievirus b3

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Control of acute cutaneous herpes simplex virus infection: T cell-mediated viral clearance is dependent upon interferon-gamma (IFN-gamma).

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Original antigenic sin and apoptosis in the pathogenesis of dengue hemorrhagic fever

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Inhibition of Alpha/Beta Interferon Signaling by the NS4B Protein of Flaviviruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

Bystander target cell lysis and cytokine production by dengue virus-specific human CD4(+) cytotoxic T-lymphocyte clones

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

based on heuristic

inferred from DOI database lookup

Gamma interferon augments Fc gamma receptor-mediated dengue virus infection of human monocytic cells

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

based on heuristic

inferred from DOI database lookup

New mouse model for dengue virus vaccine testing

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

based on heuristic

inferred from DOI database lookup

Experimental infection of chimpanzees with dengue viruses

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

based on heuristic

inferred from DOI database lookup

Cellular source of interferons in the circulation of mice with delayed hypersensitivity

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

based on heuristic

inferred from DOI database lookup

In vivo depletion of interferon-gamma leads to susceptibility of A/J mice to mouse hepatitis virus 3 infection

1 reference

https://api.crossref.org/works/10.1016%2FJ.VACCINE.2011.03.038

7 January 2021

based on heuristic

inferred from DOI database lookup

Identifiers

10.1016/J.VACCINE.2011.03.038

1 reference

Europe PubMed Central

19 September 2017

1 reference

Europe PubMed Central

19 September 2017

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q40329672&oldid=1895501906"